MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 11.05.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
75.2 M |
Marktkapitalisierung |
$ 3.94 B |
EBITDA (LTM) |
$ 167 M |
P/E (LTM) |
-82.21 |
P/S (LTM) |
2.03 |
EPS (LTM) |
-0.68 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Co-Diagnostics
CODX
|
$ 1.29 | -21.17 % | $ 1.72 M | Nasdaq Capital Market | USA |
 |
Agilent Technologies
A
|
$ 111.7 | -1.36 % | $ 34 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 19.13 | 1.32 % | $ 555 M | Nasdaq Global Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Fulgent Genetics
FLGT
|
$ 15.7 | -3.03 % | $ 475 M | Nasdaq Global Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 142.54 | -0.49 % | $ 22.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Interpace Biosciences
IDXG
|
$ 1.76 | -2.22 % | $ 7.79 M | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 19.97 | -2.54 % | $ 1.06 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Lantheus Holdings
LNTH
|
$ 93.91 | -2.86 % | $ 6.34 B | Nasdaq Global Select Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Medpace Holdings
MEDP
|
$ 415.27 | -0.93 % | $ 12 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Mettler-Toledo International
MTD
|
$ 1 031.64 | -0.99 % | $ 21.3 B | NYSE,SPB |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Myriad Genetics
MYGN
|
$ 3.58 | -1.1 % | $ 332 M | Nasdaq Global Select Market,SPB | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
NeoGenomics
NEO
|
$ 8.24 | -1.44 % | $ 1.06 B | Nasdaq Global Select Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.62 | -1.64 % | $ 417 M | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 150.85 | -5.3 % | $ 7.48 B | NYSE,SPB | USA |
 |
Natera
NTRA
|
$ 186.36 | -5.36 % | $ 18.3 B | Nasdaq Global Select Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 25.23 | -1.06 % | $ 23.9 B | NYSE |  Niderland |
 |
Guardant Health
GH
|
$ 94.92 | -3.79 % | $ 11.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 6.36 | -5.22 % | $ 568 M | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 116.38 | -0.61 % | $ 9.6 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Senseonics Holdings
SENS
|
$ 5.77 | -0.86 % | $ 241 M | NYSE American | USA |
 |
Soleno Therapeutics
SLNO
|
$ 53.01 | 0.04 % | $ 2.69 B | Nasdaq Capital Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Biomerica
BMRA
|
$ 2.34 | -2.9 % | $ 5.38 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 250.4 | -1.43 % | $ 20.8 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 438.34 | -2.2 % | $ 165 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.57 | -1.59 % | $ 205 M | Nasdaq Global Select Market | Irlanda |
 |
Celcuity
CELC
|
$ 137.68 | 2.2 % | $ 6.44 B | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Twist Bioscience Corporation
TWST
|
$ 49.17 | -7.14 % | $ 2.94 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 8.19 | -2.85 % | $ 1.78 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 186.61 | -0.71 % | $ 20.7 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |